Deutsch English Français

Contact

EP1668002

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1668002

EP1668002 - 2,4-DIOXO-3-QUINAZOLINYLARYL SULFONYLUREAS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 17.09.2010 Database last updated on 28.06.2024
Most recent event Tooltip	14.09.2012	Lapse of the patent in a contracting state New state(s): HU	published on 17.10.2012 [2012/42]
Applicant(s)	For all designated states Portola Pharmaceuticals, Inc. 270 East Grand Avenue Suite 22 South San Francisco California 94080 / US
	[2006/24]
Inventor(s)	01 / SCARBOROUGH, Robert, M. 22 Greenbrier Court Half Moon Bay, CA 94019 / US
	02 / HUANG, Wolin 872 Arcturus Circle Foster City, CA 94404 / US
	03 / PANDEY, Anjali 4506 Amiens Avenue Fremont, CA 94555 / US
	04 / BAUER, Shawn, M. 181 Beachview Avenue Pacifica, CA 94044 / US
	05 / ZHANG, Xiaoming 1089 Remsen Court Sunnyvale, CA 94087 / US
	06 / JIA, Zhaozhong, J. 1576-E Marina Court San Mateo, CA 94403 / US
	[2006/24]
Representative(s)	Wombwell, Francis, et al Forresters 15, Hamilton Square Birkenhead Merseyside CH41 6BR / GB
	[N/P]
Former [2008/41]	Wombwell, Francis, et al Potts, Kerr & Co. 15, Hamilton Square Birkenhead Merseyside CH41 6BR / GB
Former [2006/24]	Wombwell, Francis, et al Potts, Kerr & Co. 15, Hamilton Square Birkenhead Merseyside CH41 6BR / GB
Application number, filing date	04789522.2	29.09.2004
	[2006/24]
	WO2004US32921
Priority number, date	US20030508564P	03.10.2003 Original published format: US 508564 P
	[2006/24]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2005032488
	Date:	14.04.2005
	Language:	EN
	[2005/15]
	Type:	A2 Application without search report
	No.:	EP1668002
	Date:	14.06.2006
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 14.04.2005 takes the place of the publication of the European patent application.
	[2006/24]
	Type:	B1 Patent specification
	No.:	EP1668002
	Date:	11.11.2009
	Language:	EN
	[2009/46]
Search report(s)	International search report - published on:	US	12.05.2005
	(Supplementary) European search report - dispatched on:	EP	21.11.2006
Classification	IPC:	C07D409/12, C07D409/14, A61K31/517, A61P7/02	[2006/51]
	CPC:	C07D409/12 (EP,KR,US); A61P41/00 (EP); A61P43/00 (EP); A61P7/02 (EP); A61P9/10 (EP); A61P9/14 (EP); (+) C07D409/14 (EP,US) (-)
	Former IPC [2006/24]	C07D409/12, A61K31/517, A61P7/02
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/24]
Extension states	AL	24.04.2006
	HR	24.04.2006
	LT	24.04.2006
	LV	24.04.2006
	MK	24.04.2006
Title	German:	2,4-DIOXO-3-CHINAZOLINYLARYLSULFONYLHARNSTOFFE	[2006/24]
	English:	2,4-DIOXO-3-QUINAZOLINYLARYL SULFONYLUREAS	[2006/24]
	French:	SULFONYLUREES 2,4-DIOXO-3-QUINAZOLINYLARYL	[2006/24]
Entry into regional phase	24.04.2006	National basic fee paid
	24.04.2006	Search fee paid
	24.04.2006	Designation fee(s) paid
	24.04.2006	Examination fee paid
Examination procedure	24.04.2006	Examination requested [2006/24]
	13.06.2006	Amendment by applicant (claims and/or description)
	27.12.2007	Despatch of a communication from the examining division (Time limit: M04)
	01.05.2008	Reply to a communication from the examining division
	02.06.2008	Despatch of a communication from the examining division (Time limit: M02)
	03.06.2008	Reply to a communication from the examining division
	30.06.2008	Despatch of a communication from the examining division (Time limit: M02)
	26.08.2008	Reply to a communication from the examining division
	10.11.2008	Despatch of a communication from the examining division (Time limit: M02)
	22.12.2008	Reply to a communication from the examining division
	19.05.2009	Communication of intention to grant the patent
	16.09.2009	Fee for grant paid
	16.09.2009	Fee for publishing/printing paid
Opposition(s)	12.08.2010	No opposition filed within time limit [2010/42]
Fees paid	Renewal fee
	27.09.2006	Renewal fee patent year 03
	26.09.2007	Renewal fee patent year 04
	11.09.2008	Renewal fee patent year 05
	23.09.2009	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	11.11.2009
	CZ	11.11.2009
	DK	11.11.2009
	EE	11.11.2009
	FI	11.11.2009
	RO	11.11.2009
	SE	11.11.2009
	SI	11.11.2009
	SK	11.11.2009
	BG	11.02.2010
	HU	12.05.2010
	[2012/42]
Former [2010/39]	CY	11.11.2009
	CZ	11.11.2009
	DK	11.11.2009
	EE	11.11.2009
	FI	11.11.2009
	RO	11.11.2009
	SE	11.11.2009
	SI	11.11.2009
	SK	11.11.2009
	BG	11.02.2010
Former [2010/36]	CY	11.11.2009
	CZ	11.11.2009
	DK	11.11.2009
	EE	11.11.2009
	FI	11.11.2009
	RO	11.11.2009
	SE	11.11.2009
	SI	11.11.2009
	BG	11.02.2010
Former [2010/25]	CY	11.11.2009
	FI	11.11.2009
	SE	11.11.2009
	SI	11.11.2009
Former [2010/23]	FI	11.11.2009
	SE	11.11.2009
	SI	11.11.2009
Former [2010/22]	FI	11.11.2009
	SE	11.11.2009
Documents cited:	Search	[ ] - No further relevant documents disclosed
	International search	[A]WO0157037 (COR THERAPEUTICS INC [US])

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p